Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

García-Caballero M, Valle M, Martínez-Moreno JM, Miralles F, Toval JA, Mata JM, Osorio D, Mínguez A.

Nutr Hosp. 2012 Mar-Apr;27(2):623-31. doi: 10.1590/S0212-16112012000200041.

2.

Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D.

Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5.

3.

[Effects of gastric bypass on weight, blood glucose, serum lipid levels and arterial blood pressure in obese patients].

Papapietro K, Díaz E, Csendes A, Díaz JC, Braghetto I, Burdiles P, Maluenda F, Rojas J.

Rev Med Chil. 2005 May;133(5):511-6. Epub 2005 Jun 17. Spanish.

5.

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H.

Obes Surg. 2013 Jul;23(7):867-73. doi: 10.1007/s11695-013-0872-8.

PMID:
23475775
6.

Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass.

Kim S, Richards WO.

Ann Surg. 2010 Jun;251(6):1049-55. doi: 10.1097/SLA.0b013e3181d9769b.

PMID:
20485144
7.

Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery.

Yip K, Heinberg L, Giegerich V, Schauer PR, Kashyap SR.

Obes Surg. 2012 Nov;22(11):1723-9. doi: 10.1007/s11695-012-0719-8.

8.

Long-term outcomes in gastric bypass patients with and without type 2 diabetes--Waitemata District Health Board experience.

Lam AH, Kim DD, Cutfield R, Walker C, Booth M.

N Z Med J. 2013 Nov 22;126(1386):21-30.

PMID:
24316990
9.

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.

Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM.

Surgery. 2010 May;147(5):664-9. doi: 10.1016/j.surg.2009.10.059. Epub 2009 Dec 11.

PMID:
20004451
10.

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.

Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Bantle JP, Ikramuddin S.

Ann Surg. 2012 Feb;255(2):287-93. doi: 10.1097/SLA.0b013e318232b033.

PMID:
21975321
11.

Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Cohen R, Caravatto PP, Correa JL, Noujaim P, Petry TZ, Salles JE, Schiavon CA.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):375-80. doi: 10.1016/j.soard.2012.01.017. Epub 2012 Feb 2.

PMID:
22410638
12.

Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes.

Dixon JB, Hur KY, Lee WJ, Kim MJ, Chong K, Chen SC, Straznicky NE, Zimmet P.

Diabet Med. 2013 Apr;30(4):e127-34. doi: 10.1111/dme.12107.

PMID:
23278432
13.

Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2.

Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M, Zhang S, Feng X, Gong W, Zhang Z, Zhao W, Liu C, Qu S, Hu R.

Diabetes Obes Metab. 2012 Mar;14(3):262-70. doi: 10.1111/j.1463-1326.2011.01524.x. Epub 2011 Dec 27. Review.

PMID:
22051116
14.
15.

GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.

Ann Surg. 2013 May;257(5):894-9. doi: 10.1097/SLA.0b013e31826b8603.

PMID:
23579541
16.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
17.

Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.

Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK.

Diabetes. 2003 May;52(5):1098-103.

18.

Impact of weight-loss surgery and diabetes status on serum ALT levels.

Xourafas D, Ardestani A, Ashley SW, Tavakkoli A.

Obes Surg. 2012 Oct;22(10):1540-7. doi: 10.1007/s11695-012-0677-1.

19.

[Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].

Tang W, Chen Y, Pan M, Chen L, Zhang L, Wang T, Zhang X, Zhang P, Zheng C, Yu B.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):411-416. Chinese.

PMID:
28440522
20.

Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study.

Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF.

Diabetes Care. 2005 Oct;28(10):2406-11.

PMID:
16186271

Supplemental Content

Support Center